Respiratory Fluoroquinolones Are Associated With Increased Risk of Sudden Cardiac Death in Patients on Hemodialysis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis
JAMA Cardiol 2021 Oct 20;[EPub Ahead of Print], MM Assimon, PH Pun, LC Wang, SM Al-Khatib, MA Brookhart, DJ Weber, WC Winkelmayer, JE FlytheFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.